The Amyloidosis Forum | June 21, 2023 | Morning Sessions
Recording of the Morning Sessions from the Amyloidosis Forum: Advancing Drug Development in ATTR Amyloidosis in an Evolving Treatment Landscape, hosted at the U.S. Food and Drug Administration's White Oak Campus in Silver Spring, Maryland on June 21, 2023.
For more information, visit: https://amyloidosisforum.org/a....ttr-drug-development
Each session can be viewed at the following timestamps:
0:00 - Welcome and Introductions
8:32 - Overview of ATTR Amyloidosis and Treatment Advances
38:29 - How Will Shifts in the Stage of Patients with ATTR-CA Affect Ongoing and Future Clinical Trials?
46:29 - Moderated Discussion: How Will Shifts in the Stage of Patients with ATTR-CA Affect Ongoing and Future Clinical Trials?
1:19:27 - What can we collectively do for non-cardiac ATTR drug development?
1:32:19 - Moderated Discussion: What can we collectively do for non-cardiac ATTR drug development?
1:57:07 - Racial and Ethnic Disparities in ATTR
2:06:08 - Moderated Discussion: Racial and Ethnic Disparities in ATTR
2:31:00 - Patient Perspectives: ARC Survey Results
2:45:29 - Patient Perspectives: Todayโs Unmet Need
3:47:34 - Moderated Discussion: What Aspect of this Disease Have We Heard from Patients that are Not Being Measured?
Meeting recorded live via Zoom, with some patient interviews pre-recorded and edited.
-
Category
No comments found